Cytochrome c: potential as a noninvasive biomarker of drug-induced acute kidney injury

Bibliography

• Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta 2005;351(1-2):31-47
   PubMed Web of Science ®Google Scholar
• Gobe GC, Endre ZH. Cell death in toxic nephropathies. Semin Nephrol 2003;23(5):416-24
   PubMed Web of Science ®Google Scholar
• Gobe G. Identification of apoptosis in kidney tissue sections. Methods Mol Biol 2009;466:175-92
   PubMedGoogle Scholar
• Chertow GM, Burdick E, Honour M, Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16(11):3365-70
   PubMed Web of Science ®Google Scholar
• Uchino S, Kellum JA, Bellomo R, Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294(7):813-18
   PubMed Web of Science ®Google Scholar
• Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician 2008;78(6):743-50
   PubMed Web of Science ®Google Scholar
• Dieterle F, Sistare F, Goodsaid F, Renal biomarker qualification submission: a dialog between the FDA-EMEA and predictive safety testing consortium. Nat Biotechnol 2010;28(5):455-62
   PubMed Web of Science ®Google Scholar
• Endre ZH. Acute kidney injury: definitions and new paradigms. Adv Chronic Kidney Dis 2008;15(3):213-21
   PubMedGoogle Scholar
• Lameire N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol 2006;2(7):364-77
   PubMedGoogle Scholar
• Lameire N, Van Biesen W, Vanholder R. The rise of prevalence and the fall of mortality of patients with acute renal failure: what the analysis of two databases does and does not tell us. J Am Soc Nephrol 2006;17(4):923-5
   PubMed Web of Science ®Google Scholar
• Murugan R, Kellum JA. Acute kidney injury: what's the prognosis? Nat Rev Nephrol 2011;7(4):209-17
   PubMed Web of Science ®Google Scholar
• Schumer M, Colombel MC, Sawczuk IS, Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 1992;140(4):831-8
   PubMed Web of Science ®Google Scholar
• Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006;17(6):1503-20
   PubMed Web of Science ®Google Scholar
• Gobe GC, Axelsen RA. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest 1987;56(3):273-81
   PubMed Web of Science ®Google Scholar
• Hutchison CA, Batuman V, Behrens J, The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol 2011;8(1):43-51
   PubMed Web of Science ®Google Scholar
• Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol 2003;15(6):725-31
   PubMed Web of Science ®Google Scholar
• Gobe GC, Johnson DW. Distal tubular epithelial cells of the kidney: potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol 2007;39(9):1551-61
   PubMed Web of Science ®Google Scholar
• Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol 2003;23(5):460-4
   PubMed Web of Science ®Google Scholar
• Gobe G, Zhang XJ, Willgoss DA, Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 2000;11(3):454-67
   PubMedGoogle Scholar
• Hall AM, Unwin RJ, Parker N, Multiphoton imaging reveals differences in mitochondrial function between nephron segments. J Am Soc Nephrol 2009;20(6):1293-302
   PubMed Web of Science ®Google Scholar
• Racusen LC, Fivush BA, Li YL, Dissociation of tubular cell detachment and tubular cell death in clinical and experimental "acute tubular necrosis". Lab Invest 1991;64(4):546-56
   PubMedGoogle Scholar
• Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol 2008;3(2):481-90
   PubMed Web of Science ®Google Scholar
• Zhou H, Hewitt SM. Yuen PS, et al. acute kidney injury biomarkers - needs, present status, and future promise. Nephrol Self Assess Program 2006;5(2):63-71
   PubMedGoogle Scholar
• Sirota JC, Klawitter J, Edelstein CL. Biomarkers of acute kidney injury. J Toxicol 2011;2011:328120
   PubMedGoogle Scholar
• Price RG. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992;38(Suppl 1):S14-19
   PubMedGoogle Scholar
• Westhuyzen J, Endre ZH, Reece G, Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 2003;18(3):543-51
   PubMed Web of Science ®Google Scholar
• Han WK, Bailly V, Abichandani R, Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002;62(1):237-44
   PubMed Web of Science ®Google Scholar
• Mishra J, Dent C, Tarabishi R, Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365(9466):1231-8
   PubMed Web of Science ®Google Scholar
• Parikh CR, Abraham E, Ancukiewicz M, Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005;16(10):3046-52
   PubMed Web of Science ®Google Scholar
• Parikh CR, Mishra J, Thiessen-Philbrook H, Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006;70(1):199-203
   PubMed Web of Science ®Google Scholar
• Mehta RL. Urine IL-18 levels as a predictor of acute kidney injury in intensive care patients. Nat Clin Pract Nephrol 2006;2(5):252-3
   PubMedGoogle Scholar
• Coca SG, Yalavarthy R, Concato J, Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008;73(9):1008-16
   PubMed Web of Science ®Google Scholar
• Nickolas TL, O'Rourke MJ, Yang J, Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008;148(11):810-19
   PubMed Web of Science ®Google Scholar
• Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002;40(2):221-6
   PubMed Web of Science ®Google Scholar
• Mussap M, Dalla Vestra M, Fioretto P, Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002;61(4):1453-61
   PubMed Web of Science ®Google Scholar
• Supavekin S, Zhang W, Kucherlapati R, Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003;63(5):1714-24
   PubMed Web of Science ®Google Scholar
• Mishra J, Mori K, Ma Q, Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004;24(3):307-15
   PubMed Web of Science ®Google Scholar
• Mori K, Lee HT, Rapoport D, Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005;115(3):610-21
   PubMed Web of Science ®Google Scholar
• Ichimura T, Hung CC, Yang SA, Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004;286(3):F552-63
   PubMed Web of Science ®Google Scholar
• Vella JP, Harris S, Garrison K, Transcripts for kidney injury molecule-1 (Kim-1) are a specific biomarker predicting delayed graft function in kidney transplantation. Transplantation 2006;82(1):201
   Google Scholar
• O'Toole JF, Patel HV, Naples CJ, Decreased cytochrome c mediates an age-related decline of oxidative phosphorylation in rat kidney mitochondria. Biochem J 2010;427(1):105-12
   PubMedGoogle Scholar
• Iverson SL, Orrenius S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys 2004;423(1):37-46
   PubMedGoogle Scholar
• Tuominen EK, Wallace CJ, Kinnunen PK. Phospholipid-cytochrome c interaction: evidence for the extended lipid anchorage. J Biol Chem 2002;277(11):8822-6
   PubMedGoogle Scholar
• Kluck RM, Bossy-Wetzel E, Green DR, The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275(5303):1132-6
   PubMed Web of Science ®Google Scholar
• Luo X, Budihardjo I, Zou H, Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94(4):481-90
   PubMed Web of Science ®Google Scholar
• Cuttle L, Zhang XJ, Endre ZH, Bcl-X(L) translocation in renal tubular epithelial cells in vitro protects distal cells from oxidative stress. Kidney Int 2001;59(5):1779-88
   PubMedGoogle Scholar
• Li YZ, Li CJ, Pinto AV, Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells. Mol Med 1999;5(4):232-9
   PubMed Web of Science ®Google Scholar
• Goldstein JC, Waterhouse NJ, Juin P, The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2000;2(3):156-62
   PubMed Web of Science ®Google Scholar
• Beachy SH, Repasky EA. Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update. Cancer Immunol Immunother 2008;57(6):759-75
   PubMedGoogle Scholar
• Barczyk K, Kreuter M, Pryjma J, Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy. Int J Cancer 2005;116(2):167-73
   PubMedGoogle Scholar
• Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf 2007;30(4):277-94
   PubMed Web of Science ®Google Scholar
• Miller TJ, Knapton A, Adeyemo O, Cytochrome c: a non-invasive biomarker of drug-induced liver injury. J Appl Toxicol 2008;28(7):815-28
   PubMedGoogle Scholar
• Nakama T, Hirono S, Moriuchi A, Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Hepatology 2001;33(6):1441-50
   PubMed Web of Science ®Google Scholar
• Knight TR, Jaeschke H. Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion. Toxicol Appl Pharmacol 2002;181(2):133-41
   PubMedGoogle Scholar
• Jaeschke H, Gujral JS, Bajt ML. Apoptosis and necrosis in liver disease. Liver Int 2004;24(2):85-9
   PubMed Web of Science ®Google Scholar
• Tao Y, Kim J, Stanley M, Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease (ADPKD). Kidney Int 2005;67(3):909-19
   PubMedGoogle Scholar
• Brooks C, Wei Q, Cho SG, Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 2009;119(5):1275-85
   PubMed Web of Science ®Google Scholar
• Zager RA, Johnson AC, Hanson SY. Proximal tubular cytochrome c efflux: determinant, and potential marker, of mitochondrial injury. Kidney Int 2004;65(6):2123-34
   PubMedGoogle Scholar
• Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity. Kidney Int 2003;64(1):128-39
   PubMedGoogle Scholar
• Renz A, Berdel WE, Kreuter M, Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 2001;98(5):1542-8
   PubMed Web of Science ®Google Scholar
• Lund U, Rippe A, Venturoli D, Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys. Am J Physiol Renal Physiol 2003;284(6):F1226-34
   PubMed Web of Science ®Google Scholar
• Kunitomo R, Miyauchi Y, Inoue M. Synthesis of a cytochrome c derivative with prolonged in vivo half-life and determination of ascorbyl radicals in the circulation of the rat. J Biol Chem 1992;267(13):8732-8
   PubMed Web of Science ®Google Scholar